Viewing Study NCT01217957


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-03-15 @ 10:45 AM
Study NCT ID: NCT01217957
Status: COMPLETED
Last Update Posted: 2018-03-14
First Post: 2010-09-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View